Medical Technologies Database — Investigational, Unproven, HDE, and Transplant Case Management Coverage Criteria
Customize your policy alerts
Sign up for all EmblemHealth policy alerts
Know when EmblemHealth releases new policies or updates existing guidance.
Monitor payer policy activity
This document lists medical technologies, devices, and procedures that EmblemHealth considers investigational, unproven, or subject to special handling (including HDE and FEHB notes) and describes program-level transplant case management; it affects providers submitting precertification/coverage requests for EmblemHealth members, including transplant program referrals.
No material clinical or coverage changes in this revision.
Coverage Determinations and Investigational Listings
Investigational / Unproven / Conditional Coverage Entries
Entries in the Medical Technologies Database are assigned determinations (Y = covered, N = investigational/unproven, SEE NOTE) and special notes; examples below reflect listed stances and conditional handling.
Cooling caps and other scalp cooling products used to prevent chemotherapy-induced alopecia are considered incidental to the administration of chemotherapy and are not separately reimbursed. Items purchased directly by the member (for example, Chemo Cold Cap, DigniCap, ElastoGel, Paxman Scalp Cooling System, Penguin Cold Cap) are treated as supplies and are generally excluded from coverage under plans that exclude supplies. Relevant CPT codes include 0662T and 0663T. (See plan-specific benefit language for any line-of-business exceptions where the entry is marked “SEE NOTE”.)
The Medical Technologies Database lists multiple technologies and procedures as investigational or not medically necessary for specified indications. Examples include laser interstitial thermal therapy (LITT) for indications other than epilepsy and certain intracranial lesions (multiple CPTs such as 19499, 20999, 27599, 32999, 47399, 53899, 55899 designated N), microwave thermotherapy for chest wall recurrence of breast cancer (CPT 19499, N), nasal endoscopy with eustachian tube balloon dilation with mixed determinations depending on the entry, transpupillary thermotherapy for retinoblastoma where noted as Y in specific contexts, and venoplasty for relapsing–remitting multiple sclerosis (CPTs 36901–36906 designated N). The database also identifies other procedures (for example, vertebral stapling for idiopathic scoliosis, tremor analysis devices, and select telescreening algorithms) with investigational or conditional coverage stances; refer to each database row for the LOB-specific determination and effective date.
Relevant CPT / HCPCS / Miscellaneous Codes
| 0662T | scalp cooling (mentioned as incidental to chemotherapy) |
| 0663T | scalp cooling (mentioned as incidental to chemotherapy) |
| 0662T | scalp cooling (mentioned as incidental to chemotherapy) |
| 0663T | scalp cooling (mentioned as incidental to chemotherapy) |
| 0046U | gene expression / molecular assay CPT listed |
| 0049U | gene expression / molecular assay CPT listed |
| 0050U | gene expression / molecular assay CPT listed |
| 81310 | NPM1 testing (listed) |
| 81218 | CEBPA testing (listed) |
| 81245 | listed |
| 81246 | listed |
| 19499 | miscellaneous CPT referenced for certain procedures |
| 36901 | venoplasty CPT referenced |
| 36902 | venoplasty CPT referenced |
| 0046U | gene expression / molecular assay CPT listed |
| 0049U | gene expression / molecular assay CPT listed |
| 0050U | gene expression / molecular assay CPT listed |
| 81310 | NPM1 testing (listed) |
| 81218 | CEBPA testing (listed) |
| 81245 | listed |
| 81246 | listed |
| 19499 | miscellaneous CPT referenced for certain procedures |
| 36901 | venoplasty CPT referenced |
| 36902 | venoplasty CPT referenced |
Precertification, Review Requirements, and Provider Guidance
Prior Authorization Required for Investigational / HDE Devices
Precertification / case-by-case review required for investigational or HDE devices listed (including AbioCor® Implantable Replacement Heart). Providers must submit a precertification request for review. Medicare members: costs directly related to services covered by the National Coverage Determination (NCD) will be paid by CMS intermediaries/carriers when beneficiaries are enrolled in a clinical study that meets the NCD criteria.
Transplant Case Management Contact
Providers should refer transplant-eligible members to EmblemHealth’s transplant case management program for coordination of services and review. All requested transplant services are reviewed with the medical director supporting the transplant case management program and evaluated for medical necessity using evidence-based criteria.
- To request transplant case management services call 1-800-447-0768
- All transplant services are reviewed with the transplant program medical director prior to authorization
Provider Submission Requirements and Documentation
When submitting requests for investigational technologies or devices, include complete documentation of clinical indications, prior therapies/trials (e.g., LVAD consideration), patient age, and rationale for device selection. Incomplete documentation may delay review or result in denial.
- Include clinical notes, prior authorization history, and any relevant study enrollment information if applicable
- For scalp cooling products: considered incidental to chemotherapy and not separately reimbursed; document accordingly
AbioCor® Precertification and Medicare Cost-Review Note
AbioCor® Implantable Replacement Heart is FDA-approved under a Humanitarian Device Exemption (HDE) for a specific, limited patient population; precertification requests will be reviewed case-by-case for all lines of business except Medicare as noted. Ensure documentation confirms patient meets HDE criteria (e.g., <75 years old, severe biventricular end-stage heart disease, not transplant candidates, require multiple inotropic support, not eligible for LVAD destination therapy).
Key Definitions and Regulatory Notes
Program Background and Medical Technologies Database
EmblemHealth maintains a Medical Technologies Database that catalogs medical devices, procedures, and technologies and assigns each a coverage determination (for example, Y = covered, N = investigational/not medically necessary, or SEE NOTE for line-of-business exceptions). The database is used to standardize handling of items ranging from Humanitarian Device Exemption (HDE) products and scalp‑cooling devices to molecular testing and various procedural technologies. When services or devices listed as investigational or HDE are requested, precertification requests are reviewed on a case‑by‑case basis and may be escalated to the transplant program medical director or other clinical reviewers as applicable.
Transplant Candidate and Program Review Criteria
Transplant case management review
Transplant program case management and review process applies to members preparing for or having transplants.
Medical Necessity Review and Evidence Requirements
Evaluation requirements: medical necessity and evidence-based review
Requested transplant services are reviewed for medical necessity using evidence-based criteria to support care coordination and outcomes; providers should engage transplant case management for coordination.
- All requested transplant services undergo medical necessity review using evidence-based criteria.
- Contact transplant case management for coordination of evaluations and care planning.
Transplant Center and Program-Level Requirements
Center requirements: medical director review and program oversight
All transplant services are reviewed with the medical director assigned to support the transplant case management program; program-level oversight may be required for transplant-related precertification and case management.
- Medical director involvement is required for review of transplant services.
- Transplant program case management provides coordination and oversight for members preparing for or having transplants.
Post-Transplant and Follow-up Review
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.